|
|
M H Wang, A Skeel, E J Leonard
J Clin Invest. 1996;
97(3):720
doi:10.1172/JCI118470
Abstract |
Full text
| PDF

M
acrophage stimulating protein (MSP), which is secreted as biologically inactive pro-MSP, is activated to MSP by cleavage at a single peptide bond. Our objectives were to determine the form of MSP in circulating blood and to study proteolytic activation of pro-MSP by its target cell. Western blot of immunoaffinity-purified serum MSP showed that all the protein was pro-MSP, without detectable MSP. The circulating form of the protein is therefore pro-MSP, and conversion to MSP does not occur when blood is shed. Incubation of radiolabeled pro-MSP with murine peritoneal macrophages caused proteolytic cleavage to predominantly inactive fragments. Among several protease inhibitors, soybean trypsin inhibitor was one of two that inhibited nonspecific cleavage and revealed a macrophage proteolysis of pro-MSP, and certain concentrations enhanced cleavage to mature MSP. Macrophage membranes had nonspecific and specific pro-MSP proteolytic activity, which was not present in macrophage culture fluids. The results suggest that control of MSP activity can occur at the level of the target cell by proteolytic cleavage of pro-MSP to mature MSP or to inactive fragments.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(22)
| Title and authors |
Publication |
Year |
The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
Jae-Min Yuk, Dong-Min Shin, Hye-Mi Lee, Jwa-Jin Kim, Sun-Woong Kim, Hyo Sun Jin, Chul-Su Yang, Kyeong Ah Park, Dipanjan Chanda, Don-Kyu Kim, Song Mei Huang, Sang Ki Lee, Chul-Ho Lee, Jin-Man Kim, Chang-Hwa Song, Soo Young Lee, Gang Min Hur, David D Moore, Hueng-Sik Choi, Eun-Kyeong Jo
|
Nat Immunol
|
2011 |
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.
Karin List, Peter Kosa, Roman Szabo, Alexandra L Bey, Chao Becky Wang, Alfredo Molinolo, Thomas H Bugge
|
The American Journal of Pathology
|
2009 |
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease
Anna Latiano, Orazio Palmieri, Giuseppe Corritore, Maria Rosa Valvano, Fabrizio Bossa, Salvatore Cucchiara, Massimo Castro, Gabriele Riegler, Domenica De Venuto, Renata D'Incà , Angelo Andriulli, Vito Annese
|
Inflamm Bowel Dis
|
2009 |
Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein
Makiko Kawaguchi, Hiroshi Orikawa, Takashi Baba, Tsuyoshi Fukushima, Hiroaki Kataoka
|
FEBS Journal
|
2009 |
Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde?
Teresa Rampino, Marilena Gregorini, Antonio Dal Canton
|
Cytokine & Growth Factor Reviews
|
2009 |
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis
P Goyette, C Lefebvre, A Ng, S R Brant, J H Cho, R H Duerr, M S Silverberg, K D Taylor, A Latiano, G Aumais, C Deslandres, G Jobin, V Annese, M J Daly, R J Xavier, J D Rioux
|
Mucosal Immunol
|
2008 |
Novartis Foundation Symposia
Alberto Bardelli, Paolo M. Comoglio
|
Ciba Foundation Symposium 212 - Plasminogen-Related Growth Factors
|
2007 |
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.
Alana L Welm, Julie B Sneddon, Carmen Taylor, Dimitry S A Nuyten, Marc J van de Vijver, Bruce H Hasegawa, J Michael Bishop
|
Proc. Natl. Acad. Sci. U.S.A.
|
2007 |
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
Mike A Leonis, Megan N Thobe, Susan E Waltz
|
Future Oncology
|
2007 |
Novartis Foundation Symposia
Edward J. Leonard
|
Ciba Foundation Symposium 212 - Plasminogen-Related Growth Factors
|
2007 |
|